These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30504333)

  • 41. Thalassemia 2016: Modern medicine battles an ancient disease.
    Rund D
    Am J Hematol; 2016 Jan; 91(1):15-21. PubMed ID: 26537527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
    Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M
    N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematopoietic stem cell transplantation in thalassemia.
    Gaziev J; Sodani P; Lucarelli G
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S41. PubMed ID: 18724298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haematopoietic stem cell transplantation for thalassaemia in Chinese patients.
    Li CK; Lee V; Shing MM; Leung TF
    Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):39-41. PubMed ID: 19494396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of luspatercept for thalassemia in adults.
    Cappellini MD; Taher AT
    Blood Adv; 2021 Jan; 5(1):326-333. PubMed ID: 33570654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New strategies in the treatment of the thalassemias.
    Schrier SL; Angelucci E
    Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of Transfusion and Iron Chelation in Thalassemias.
    Porter JB; Garbowski MW
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):247-259. PubMed ID: 29458730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia.
    Isgrò A; Gaziev J; Sodani P; Lucarelli G
    Ann N Y Acad Sci; 2010 Aug; 1202():149-54. PubMed ID: 20712786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
    Arnold SD; Bhatia M; Horan J; Krishnamurti L
    Br J Haematol; 2016 Aug; 174(4):515-25. PubMed ID: 27255787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative donor transplant of benign primary hematologic disorders.
    Tolar J; Sodani P; Symons H
    Bone Marrow Transplant; 2015 May; 50(5):619-27. PubMed ID: 25665040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2017 Clinical trials update in new treatments of β-thalassemia.
    Makis A; Hatzimichael E; Papassotiriou I; Voskaridou E
    Am J Hematol; 2016 Nov; 91(11):1135-1145. PubMed ID: 27502996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
    Dong AC; Rivella S
    Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene Therapy For Beta-Thalassemia: Updated Perspectives.
    Karponi G; Zogas N
    Appl Clin Genet; 2019; 12():167-180. PubMed ID: 31576160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unrelated and related donor transplantation for beta-thalassemia major: A single-center experience from India.
    John MJ; Mathew A; Philip CC; Singh S; Tanuja T; Kakkar N
    Pediatr Transplant; 2018 Aug; 22(5):e13209. PubMed ID: 29726078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen.
    Bradley MB; Sattler RM; Raftopoulos H; Ward M; Grossman IR; Townes TM; Ryan TA; Bank A
    Biol Blood Marrow Transplant; 2002; 8(8):453-61. PubMed ID: 12234171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic stem cell transplantation for thalassemia major.
    Mathews V; Srivastava A; Chandy M
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1187-200. PubMed ID: 25459187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).
    Antmen B; Karakaş Z; Yeşilipek MA; Küpesiz OA; Şaşmaz İ; Uygun V; Kurtoğlu E; Oktay G; Aydogan G; Akın M; Salcioglu Z; Vergin C; Kazancı EG; Ünal S; Çalışkan Ü; Aral YZ; Türkkan E; Meral Güneş A; Tunç B; Gümrük F; Ayhan AC; Söker M; Koç A; Oymak Y; Ertem M; Timur Ç; Yıldırmak Y; İrken G; Apak H; Biner B; Eren TG; Işık Balcı Y; Koçak Ü; Karasu G; Akkaynak D; Patıroğlu T
    Eur J Haematol; 2019 Feb; 102(2):123-130. PubMed ID: 30300449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D; Cassinerio E; Marcon A; Mancarella M; Fraquelli M; Pedrotti P; Cappellini MD
    Ann Hematol; 2017 Nov; 96(11):1931-1936. PubMed ID: 28875336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.